Tender Number 1

Auto-translated from da

Original title: Udbudsnummer 1

Amgros I/S

Published: Mar 13, 2026

Updated: May 6, 2026

Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Pfizer ApS; Orifarm A/S; Sandoz A/S; 2care4 ApS; Biogen (Denmark) A/S — DKK 2,321,995,000

Browse open Health & Medical tenders in Denmark

About This Opportunity

Translated

This tender, designated as Tender Number 1, concerns the supply of specific pharmaceutical products. The lot includes the drug Etanercept, identified by ATC code L04AB01. The specified dosage form is an injection, with a strength of 10 mg, supplied in a vial. The unit value is 7 mg, and the quantity required is 602 units. Each tender number is considered an independent sub-contract, and suppliers can bid on one, multiple, or all available tender numbers. Awards will be made separately for each tender number. The quantity indicated ('quantity in units') reflects the historical consumption over the preceding 12-month period. This procurement is part of a larger tender process for various medicinal products, and this specific lot focuses on the supply of Etanercept for healthcare needs. Bidders must refer to the tender conditions for detailed instructions on submitting offers for individual tender numbers.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Denmark, Europe, this opportunity is open to firms and consortiums, with an estimated budget of DKK 350,000.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: da

Udbudsnummeret (delkontrakten) omfatter følgende lægemidler: ATC Kode: L04AB01 · Generisk navn: Etanercept · Dispenseringsform: Injektionsvæske · Styrke: 10 mg · Pakning: Hætteglas · Enhedsværdi: 7 mg · Mængde i enheder: 602. Hvert udbudsnummer anses for en selvstændig delkontrakt og udbydes uafhængigt af de øvrige udbudsnumre. En leverandør kan således vælge at give tilbud på ét, flere eller alle udbudsnumre, og tildeling sker separat for hvert enkelt udbudsnummer. En leverandør kan således tildeles en, flere eller alle delkontrakter. Der henvises til udbudsbetingelserne, herunder om afgivelse af tilbud under de enkelte udbudsnumre. Under betegnelsen "mængde i enheder" ovenfor er angivet det historiske forbrug af lægemidlerne under udbudsnummeret i den foregående 12 måneders periode, men leverandøren skal påregne, at det reelle forbrug kan afvige væsentligt derfra. Baggrunden herfor er, at der er tale om lægemidler til patientbehandling på de offentlige sygehuse, hvor patientens behov skal imødekommes. De udbudte lægemidler er endvidere omfattet af en eller flere anbefalinger og/eller behandlingsvejledninger fra Medicinrådet, og forbruget af de forskellige lægemidler kan i væsentligt omfang blive påvirket deraf. Det beror på, at det udbudte lægemiddel er omfattet af en eller flere anbefalinger og/eller behandlingsvejledninger fra Medicinrådet, som vurderer, hvilke af de udbudte lægemidler der anbefales til behandling til forskellige patientpopulationer, eventuelt således at visse lægemidler anses som ligestillede mulige førstevalg, anbefales til anvendelse i prioriteret rækkefølge eller lignende. Medicinrådets vurdering kan derfor have væsentlig betydning for, hvilke af de udbudte lægemidler der anvendes inden for forskellige terapiområder og patientpopulationer, og forbruget af de enkelte lægemidler kan tillige bero på gældende aftalepriser. Den anslåede værdi i pkt. 5.1.5 er baseret på et skøn over det anslåede potentielle indkøb under udbudsnummeret (delkontrakten), og den maksimale værdi af delkontrakten er beregnet som 130 % af den anslåede værdi for udbudsnummeret (delkontrakten). Der henvises tillige til udbudsbetingelserne og rammeaftalen.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 13, 2026. Last refreshed 51 days ago. Original language: da. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Amgros I/S

Amgros I/S has issued 155 procurement notices on BidsFactory, including 12 currently open and 60 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Media & Communications. All notices are published for Denmark. Notices are distributed via TED - Tenders Electronic Daily (EU) and Denmark Udbud. Most recent publication: June 25, 2026.

Frequently asked questions about this tender

How much was the contract awarded for?

Pfizer ApS; Orifarm A/S; Sandoz A/S; 2care4 ApS; Biogen (Denmark) A/S was awarded the contract for DKK 2,321,995,000. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Denmark. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Pfizer ApS; Orifarm A/S; Sandoz A/S; 2care4 ApS; Biogen (Denmark) A/S. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Amgros I/S in Denmark. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.